Sam Bright examines the contribution of Brexit to our current healthcare crisis.

There are growing post-Brexit differences between which medicines are approved for use in Northern Ireland and the rest of the UK, research from a health think tank indicates.

Specialisms such as dentistry have shortages and EU exit still causes issues with medicines in Northern Ireland, thinktank finds.

The impact of Brexit has only added fuel to the fire of severe challenges facing health and social care in the UK, warns the Nuffield Trust.

The Nuffield Trust think tank has published a new report on the impact of Brexit on the UK’s health and care services. The ongoing monitoring work, funded by the Health Foundation, covers the impact on the NHS and social care workforce, medicine and medical devices supply and the economic cost, and reveals negative effects across these areas.

THE turning point was the Brexit referendum. Before voting to leave the EU in June 2016, medicine shortages were not something the UK often had to worry about.

EU moves to guarantee supply of medicines to Northern Ireland have so far worked but there are looming issues, peers have heard.

Probably not the anniversary present the government was hoping to offer the public.

Britain will continue trying to recruit the health workers it needs from abroad, but getting back those its lost to the EU is unlikely - as ITV News Europe Editor James Mates reports.

In an exclusive interview with the Record, Dr Arianna Andreangeli tells how the NHS has further deteriorated since Brexit. / Scotland is facing a crisis in its National Health Service due to Covid and Tory austerity - but Brexit has caused further deadly delays in our hospitals.

From NHS staff shortages to export woes, the effects of the 2016 vote are still being felt.

Patients put at risk as crisis hits supplies of vital antibiotics, HRT and anti-depressants. / Vital antibiotics, hormone replacement therapy (HRT) and attention deficit hyperactivity disorder (ADHD) drugs are among those in desperately short supply this winter – with the NHS forced to pay over the odds to get drugs into Britain.

Bloc plans to bulk-buy key drugs for all 27 countries, potentially leaving Britain ‘behind in the queue’. / “Europe is securing access to key drugs and vaccines as a single region, with huge influence and buying power. As a result of Brexit the UK is now isolated from this system, so our drug supplies could be at risk in the future,” said Dr Andrew Hill, an expert on the pharmaceutical trade.

British pharmacists are struggling to get their hands on certain medicines for cancer, epilepsy, diabetes and menopause as drug supply issues intensify in the country.

‘The medicines supply chain is broken at every level,’ warns Dr Leyla Hannbeck.

A report from the Nuffield Trust has concluded that the UK is facing “constantly elevated medicine shortages,” including some antibiotics and epilepsy drugs, which are being fuelled by Brexit.

A report is warning the UK's medicine supply chain is "broken" with drug shortages becoming the "new normal" in Britain.